These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 27112344)

  • 41. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
    Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
    Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A qualitative exploration of mental health services provided in community pharmacies.
    Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
    PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of a Community-Based Medication Management Review Service in Jordan: A Prospective Randomized Controlled Study.
    Basheti IA; Tadros OK; Aburuz S
    Pharmacotherapy; 2016 Oct; 36(10):1075-1086. PubMed ID: 27582175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
    Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.
    Asayut N; Sookaneknun P; Chaiyasong S; Saramunee K
    Int J Pharm Pract; 2018 Feb; 26(1):16-27. PubMed ID: 28795519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-prescription medicines: a process for standards development and testing in community pharmacy.
    Benrimoj SC; Gilbert A; Quintrell N; Neto AC
    Pharm World Sci; 2007 Aug; 29(4):386-94. PubMed ID: 17333499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a community pharmacy disaster preparedness manual.
    Noe B; Smith A
    J Am Pharm Assoc (2003); 2013; 53(4):432-7. PubMed ID: 23892819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How involvement of community pharmacies improves accessibility to and awareness about flu vaccination? - An example from Estonia.
    Sepp K; Kukk C; Cavaco A; Volmer D
    Expert Rev Vaccines; 2020 Oct; 19(10):983-990. PubMed ID: 32940097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Summative service and stakeholder evaluation of an NHS-funded community Pharmacy Emergency Repeat Medication Supply Service (PERMSS).
    Nazar H; Nazar Z; Simpson J; Yeung A; Whittlesea C
    BMJ Open; 2016 Jan; 6(1):e009736. PubMed ID: 26787252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
    Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
    Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are patient's simply unaware? A cross-sectional study of website promotion of community pharmacy adherence-related services in Tennessee.
    Hohmeier KC; Borja-Hart N
    Res Social Adm Pharm; 2016; 12(6):1004-1009. PubMed ID: 26706404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879.
    Walsh S; Irwin AN; Anderson L; Zehrung C
    J Am Pharm Assoc (2003); 2019; 59(4S):S112-S116. PubMed ID: 31010785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring weight management recommendations across Australian community pharmacies using case vignettes.
    Fakih S; Marriott JL; Hussainy SY
    Health Educ Res; 2014 Dec; 29(6):953-65. PubMed ID: 25149189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia.
    Swetenham K; Rowett D; Stephenson D
    Aust Health Rev; 2014 May; 38(2):238-41. PubMed ID: 24670916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defining professional pharmacy services in community pharmacy.
    Moullin JC; Sabater-Hernández D; Fernandez-Llimos F; Benrimoj SI
    Res Social Adm Pharm; 2013; 9(6):989-95. PubMed ID: 23591411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.